483
Kaysersberg Pharmaceuticals SASKaysersberg Pharmaceuticals SAS – FDA 483, Jul 19, 2016
Record Details
Kaysersberg Pharmaceuticals SAS, a drug manufacturer in Kaysersberg, France, was cited for multiple deficiencies during an FDA inspection. Key issues include inadequate investigations into discrepancies, insufficient environmental monitoring in aseptic areas, and failures in sanitation, cleaning, calibration, and process control procedures. The observations indicate a lack of robust quality systems and process validation.
View Company Profile
ID · 0c0bf131-b1c2-42bc-9baa-13273ff535d0
Other documents for Kaysersberg Pharmaceuticals SAS
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.